Unique Laser Platform Improves Skin Health and AppearanceUnique Laser Platform Improves Skin Health and Appearance

Healthy skin is a cornerstone of aesthetic medicine. To many, this suggests a daily regimen of creams and serums, but the laser is also a tool relied upon by patients and practitioners alike for skin health.

Kevin A. Wilson

December 10, 2024

3 Min Read
The Aesthetic Guide logo in a gray background | The Aesthetic Guide

Healthy skin is a cornerstone of aesthetic medicine. To many, this suggests a daily regimen of creams and serums, but the laser is also a tool relied upon by patients and practitioners alike for skin health.

Powerful yet gentle, the ADVATx dualwavelength laser system from Advalight (Copenhagen, Denmark) treats skin types I-V, with 25 Food and Drug Administration (FDA)/ Conformité Européene (CE)-cleared indications to date. According to Raminder Saluja, MD, medical director of the Saluja Cosmetic and Laser Center (Huntersville, N.C.), this unique platform has unrivaled versatility and capability, making it a mainstay of her thriving practice. "ADVATx treats the entire spectrum of anti-aging and skin health issues, from pigmented* and vascular lesions to fine lines and wrinkles, pore size and texture, as well as rosacea, acne and acne scarring,” she stated. “It is among the most utilized devices in my practice.”

Healthy Skin Improvements

While it has leading therapeutic utility, ADVATx is also commonly used to renew and refresh skin as a popular stand-alone treatment or as a precursor to more advanced intervention. A gold standard vascular laser used to treat inflammatory conditions, the 589 nm wavelength has been shown to reduce porphyrins,1 high levels of which have been linked to inflammatory skin diseases.2 The 1319 nm wavelength is a powerhouse for collagen remodeling and is well-suited to the platform because its target chromophore is water, not melanin. “I typically begin with the 589 nm to target vascular and pigmented lesions,* followed by the 1319 nm wavelength for fine lines, wrinkles and deeper dermal remodeling,” Dr. Saluja explained.

“A regimen of three sessions at six-week intervals has been shown to significantly reduce the visible signs of aging and restore a healthy, youthful skin appearance,” she commented. “Satisfied with these initial results, many opt for additional treatments. We encourage this because once the skin is treated and photodamage,* such as generalized erythema, broken capillaries and benign pigmentation* has been cleared, the skin appears refreshed and healthier. This process also minimizes or eliminates competing chromophores, thereby enhancing the efficacy of more intensive treatments, such as full-face CO2 laser or plasma resurfacing,” Dr. Saluja noted. It also helps to reduce post-procedural erythema, which is a common side effect experienced with more aggressive interventions.

Comfort and Compliance

“When assessing skin health, physicians consider conditions such as actinic keratoses and other dermatologic concerns. However, the overall perception of a patient’s skin health is often closely tied to the extent of photodamage,”* she continued. “ADVATx effectively clears photodamage,* restoring the natural skin tone and enhancing the appearance by making patients look like an improved version of themselves.” The high tolerability of the treatment also plays a significant role in maximizing patient engagement and compliance. “The comfort of the procedure encourages patients to return for follow- up sessions, keeping them motivated and invested in their treatment outcomes.”

ADVATx is also excellent in combination with injectables, Dr. Saluja added. “The improvement in skin health provides a visible enhancement to treatment with fillers and neurotoxin and can take those results beyond the next level because healthy skin is the subtle but essential foundation for aesthetic improvement.”

*ADVATx is CE-cleared for the treatment of hyperpigmentation with the 589 nm wavelength on skin types I-V.

References:

1. Data on file, Advalight (Copenhagen, Denmark)

2. Barnard E, Johnson T, Ngo T, Arora U, et al. Porphyrin Production and Regulation in Cutaneous Propionibacteria. mSphere. 2020 Jan 15;5(1):e00793-19.

Subscribe to receive the latest in aesthetic medicine.
Get breaking developments, expert product comparisons, clinical roundtables, and practice strategies—all for free.